Analystreport

Deciphera Pharmaceuticals (NASDAQ: DCPH) had its price target lowered by analysts at B. Riley from $52.00 to $43.00. They now have a "buy" rating on the stock.

Deciphera Pharmaceuticals, Inc.  (DCPH) 
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: deciphera.com/investor-relations